BUSINESS
Mitsubishi Tanabe Withdraws Petitions for Injunction against 3 Generic Makers Over Talion Patent Infringement
Mitsubishi Tanabe Pharma said on October 26 that it has withdrawn petitions seeking an injunction against patent infringements by three generic makers over its anti-allergy treatment Talion (bepotastine). The company presented the petition against three companies: Towa Pharmaceutical, Shiono Chemical,…
To read the full story
Related Article
- Mitsubishi Tanabe Seeks to Block Talion Generic Launches by 3 Makers
September 26, 2017
BUSINESS
- Ultragenyx Seeks Japan Approval for GSDIa Gene Therapy
July 1, 2026
- Specialist Hails Wegovy as “Game Changer” for MASH Treatment
July 1, 2026
- Alfresa Boosts Stake in ENT Cell Sheet Startup
July 1, 2026
- Eisai, UCL Renew Neuroscience Alliance to 2030
July 1, 2026
- Asahi Kasei Nabs Japan Rights to Additional Empaveli Indications
July 1, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





